Skip to Main Content

Paper Details

Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
J Urol
1
2023
Apalutamide, Prostate Cancer, apalutamide, cancer, low-grade tumors, men, patients, prostate cancer
Author NameAffiliation
Lawrence D TrueUniversity of Washington
Bruce MontgomeryUniversity of Washington
Bruce MontgomeryClinical Research Division, Fred Hutchinson Cancer Research Center
Bruce MontgomeryVA Puget Sound Health Care System and Prostate Cancer Foundation POPCAP Network
Yang LiuInc.
Elai DavicioniInc.
Kenneth J PientaThe James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonClinical Research Division, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonClinical Research Division, Fred Hutchinson Cancer Research Center
Peter S NelsonFred Hutchinson Cancer Research Center
Daniel W LinUniversity of Washington
Jonathan L WrightUniversity of Washington
  • 1 - 15

Datasets

Release 1.2